Quick Takeaways
- RayzeBio, Inc. has 16 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
Insider Transactions Reported by 16 Insiders of RayzeBio, Inc.
- Location
- San Diego, CA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 27 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
RayzeBio, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| venBio Global Strategic Fund III, L.P. | 10%+ Owner | $322,385,125 | Mixed | 19 Sep 2023 | ||
| Redmile Group, LLC | 10%+ Owner | $116,106,625 | Mixed | 19 Sep 2023 | ||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10%+ Owner | $97,365,375 | Mixed | 19 Sep 2023 | ||
| Richard A. Heyman | Director | $0 | Mixed | 26 Feb 2024 | ||
| Kenneth Song | PRESIDENT AND CHIEF EXECUTIVE, Director | $0 | Mixed | 26 Feb 2024 | ||
| VIKING GLOBAL INVESTORS LP | 10%+ Owner | $0 | Mixed | 26 Feb 2024 | ||
| Maha Katabi | Director | $0 | Mixed | 26 Feb 2024 | ||
| Susan Moran | Chief Medical Officer | $0 | Mixed | 26 Feb 2024 | ||
| Arvind Kush | Chief Financial Officer | $0 | Mixed | 26 Feb 2024 | ||
| Angie You | Director | Mixed | 26 Feb 2024 | |||
| Aaron Royston | Director | Mixed | 14 Sep 2023 | |||
| Versant Ventures VII GP-GP, LLC | 10%+ Owner | Mixed | 14 Sep 2023 | |||
| Mary Tagliaferri | Director | Mixed | 26 Feb 2024 | |||
| Yi Larson | Director | Mixed | 26 Feb 2024 | |||
| Christy J. Oliger | Director | Mixed | 26 Feb 2024 | |||
| Timothy van Hauwermeiren | Director | Mixed | 26 Feb 2024 |
Top shareholders of RayzeBio, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| venBio Global Strategic Fund III, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,158,162
|
$322,385,125 | — | 19 Sep 2023 | |
| Redmile Group, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,857,706
|
$116,106,625 | — | 19 Sep 2023 | |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,557,846
|
$97,365,375 | — | 19 Sep 2023 |
Recent Insider Transactions by Companies or Individuals for RayzeBio, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.